These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4030670)

  • 1. Cell mediated immunity in leprosy with neurological complications.
    Dham SK; Kumar V; Tutakne MA
    J Assoc Physicians India; 1985 Apr; 33(4):259-61. PubMed ID: 4030670
    [No Abstract]   [Full Text] [Related]  

  • 2. Is neopterin--a marker of cell mediated immune response--helpful in classifying leprosy?
    Schmutzhard E; Fuchs D; Hausen A; Reibnegger G; Wachter H
    East Afr Med J; 1986 Sep; 63(9):577-80. PubMed ID: 3792248
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is there a reactivation of cellular immunity in erythema nodosum leprosum?].
    Stach JL; Fumoux F; Digoutte JP
    Acta Leprol; 1981; 85():83-92. PubMed ID: 6805239
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of cell mediated immunity in leprosy.
    Dubey GK; Joglekar VK; Hardas UD; Chaubey BS
    Lepr India; 1981 Apr; 53(2):197-203. PubMed ID: 7253571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nervous system leprosy in metropolitan France. Remarks on problems posed by it].
    Schmitt J; Schmidt C; Adam-Goldberg E; Floquet J
    Ann Med Interne (Paris); 1976 Mar; 127(3):247-51. PubMed ID: 962246
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on cellular immunity in leprosy. I. Lysosomal enzymes.
    Avila JL; Convit J
    Int J Lepr Other Mycobact Dis; 1970; 38(4):359-64. PubMed ID: 4929372
    [No Abstract]   [Full Text] [Related]  

  • 7. The effectiveness of corticosteroids in the treatment of long-term nerve function impairment.
    Croft R; Richardus JH; Smith WC
    Lepr Rev; 1996 Dec; 67(4):342-3. PubMed ID: 9033206
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of cellular immunity in indeterminate hanseniasis].
    Neves RA; Teixeira LA; Neves RG; Manhães LF
    Rev Bras Malariol Doencas Trop; 1982; 34():108-15. PubMed ID: 7187517
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M. leprae-HIV co-infection: pattern of immune response in vivo and in vitro.
    Nery JA; Sampaio EP; Galhardo MC; Perissé AR; Vieira LM; Salles AM; Sarno EN
    Indian J Lepr; 2000; 72(2):155-67. PubMed ID: 11008656
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T; Myklestad B; Samuel DR; Myrvang B
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological complications of peripheral and cutaneous T-cell lymphomas.
    Kaufman DK; Habermann TM; Kurtin PJ; O'Neill BP
    Ann Neurol; 1994 Oct; 36(4):625-9. PubMed ID: 7944294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis (NF1) and neuroleprosy: immunoreaction against pathologic Schwann-cells. Physiopathogenetic observations].
    Gerosa PL; Spinelli M; Giussani G; Vai C; Fontana A; Canepari C
    Minerva Med; 2001 Apr; 92(2):89-97. PubMed ID: 11323571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition and leprosy--an analytical review.
    Edelman R
    Lepr India; 1979 Jul; 51(3):376-88. PubMed ID: 117258
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy.
    Spierings E; De Boer T; Zulianello L; Ottenhoff TH
    Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leprosy.
    Hendrick SS; Wilkin JK
    Am Fam Physician; 1982 Nov; 26(5):161-6. PubMed ID: 7148625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of cell mediated immunity in leprosy: changing trends in the immunological spectrum of the disease.
    Saha K; Mittal MM
    Clin Exp Immunol; 1971 Jun; 8(6):901-9. PubMed ID: 5091616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy and leprosy: the consequences of alterations of cell-mediated and humoral immunity during pregnancy and lactation.
    Duncan ME; Pearson JM; Ridley DS; Melsom R; Bjune G
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):425-35. PubMed ID: 6892021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.